ABT vs STEP · P/E 25, rev $44.33B vs rev $1.99B
Abbott Laboratories (ABT) versus Stepstone Group Inc (STEP) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Stepstone Group Inc (STEP) is a asset management company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported STEP revenue for 2026-03-31 was $1.99B. Net income was -$535.8M. Revenue was up 69.7% from 2025-03-31 to 2026-03-31. STEP currently screens at market cap $5.78B.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. STEP currently screens at market cap $5.78B.
Not investment advice. Open the ABT and STEP stock pages for the full models.
Not investment advice.